The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

Lenacapavir is an approved HIV treatment given as a twice-yearly injection. In 2025, Nigeria joined global leaders in ...

"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced final data from the LATITUDE phase III trial, confirming its ...

ViiV Healthcare’s long-acting Cabenuva for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges: London, UK Friday, February 20 ...

Researchers have created 50 induced pluripotent stem cell lines from 18 people with HIV to model HIV infection in the laboratory.

Gilead Sciences, Inc. today announced details of new clinical and real-world data from its innovative HIV treatment and ...

In 1990, I finished my PhD on primate evolution and went to my postdoc in Davis, California, USA. It was meant to be on fruit fly ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.